Long-Term Efficacy of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled POS: Results from a Phase III Open-Label Extension Trial

被引：0
|
作者：
Chung, Steve
Faught, Raymond Edward
Husain, Aatif
Isojarvi, Jouko
Doty, Pamela
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A376 / A376
页数：1
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [32] Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
    Papp, Kim A.
    de Vente, Saskia
    Zeng, Jiewei
    Flack, Mary
    Padilla, Byron
    Tyring, Stephen K.
    [J]. DERMATOLOGY AND THERAPY, 2021, 11 (02) : 487 - 497
  • [33] Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial
    Kim A. Papp
    Saskia de Vente
    Jiewei Zeng
    Mary Flack
    Byron Padilla
    Stephen K. Tyring
    [J]. Dermatology and Therapy, 2021, 11 : 487 - 497
  • [34] Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial
    Toledo, Manuel
    Brandt, Christian
    Quarato, Pier Paolo
    Schulz, Anne-Liv
    Cleveland, Jody M.
    Wagener, Gilbert
    Klein, Pavel
    [J]. EPILEPSY & BEHAVIOR, 2021, 118
  • [35] Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial
    Scheffer, Ingrid E.
    Halford, Jonathan J.
    Miller, Ian
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Shiloh-Malawsky, Yael
    Wong, Matthew
    Zolnowska, Marta
    Checketts, Daniel
    Dunayevich, Eduardo
    Devinsky, Orrin
    [J]. EPILEPSIA, 2021, 62 (10) : 2505 - 2517
  • [36] Safety And Efficacy Of Adjunctive Lacosamide In Chinese And Japanese Adult Epilepsy Patients With Focal Seizures: Interim Data From An Open-Label Extension Trial
    Inoue, Y.
    Du, X.
    Hoshii, N.
    Sasamato, H.
    [J]. EPILEPSIA, 2019, 60 : 62 - 62
  • [37] Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial
    Guerrini, Renzo
    Rosati, Anna
    Bradshaw, Kate
    Giorgi, Luigi
    [J]. EPILEPSIA, 2014, 55 (04) : 568 - 578
  • [38] Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
    Shaibani, Aziz
    Biton, Victor
    Rauck, Richard
    Koch, Brigitte
    Simpson, Jeffrey
    [J]. EUROPEAN JOURNAL OF PAIN, 2009, 13 (05) : 458 - 463
  • [39] Long-Term Efficacy of Adjunctive Cariprazine in Patients With MDD: Results From an Open-Label 26-Week Safety Study
    Masand, Prakash
    Vieta, Eduard
    Waraich, Simranpreet
    Kramer, Ken
    Kerolous, Majid
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 263 - 264
  • [40] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345